Update on Resection Strategies for Hepatocellular Carcinoma: A Narrative Review.

Autor: Lee, Jun Suh¹ (AUTHOR) rudestock@gmail.com, Choi, Hyeong Woo¹ (AUTHOR), Kim, Ji Su¹ (AUTHOR), Lee, Tae Yoon¹ (AUTHOR), Yoon, Young Chul¹ (AUTHOR) k07yyc@catholic.ac.kr

Publikováno v: Cancers. Dec2024, Vol. 16 Issue 23, p4093. 22p.

Abstract No. 439: Caval perforation of inferior vena cava filters on CT: a pictorial essay

Autor: Jeong, D., Malalis, C., Virmani, S., Souman, T., Gimpert, M., Pillai, A.K.

Publikováno v: In Journal of Vascular and Interventional Radiology March 2012 23(3) Supplement:S174-S174

Apatinib plus drug-eluting bead transarterial chemoembolization as bridging therapy to surgical resection displays an acceptable efficacy and safety profile in hepatocellular carcinoma patients.

Autor: Jingwei Yan¹ yan20483@163.com, Yumei Sun², Daguang Fan¹, Wei Mu³

Publikováno v: Indian Journal of Cancer. Oct-Dec2023, Vol. 60 Issue 4, p562-569. 9p.

Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.

Autor: Kulik LM; Division of Hepatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Hospital, Chicago, Illinois, USA., Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, Hunter RD, Nemcek AA Jr, Abecassis MM, Haines KG 3rd, Salem R

Publikováno v: Journal of surgical oncology [J Surg Oncol] 2006 Dec 01; Vol. 94 (7), pp. 572-86.

Conversion therapy and maintenance therapy for primary hepatocellular carcinoma.

Autor: Hongyuan Zhou¹, Tianqiang Song¹ tjchi@Hotmail.com

Publikováno v: BioScience Trends. Jun2021, Vol. 15 Issue 3, p155-160. 6p.